v3.25.1
Supplementary Financial Statement Information
12 Months Ended
Dec. 31, 2024
Supplementary Financial Statement Information [Abstract]  
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 17 – SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

 

a. Research and development expenses – net

 

   Year ended December 31, 
(in thousands)  2024   2023   2022 
Payroll and related expenses  $3,078   $5,265   $6,371 
Research and development services   5,039    9,853    8,264 
Materials   553    1,880    2,044 
Share Based Compensation   916    524    876 
Depreciation   497    802    740 
Other   540    911    1,605 
    10,623    19,235    19,900 
Israel Innovation Authority participation in research and development costs and royalties payable   
-
    (223)   (1,207)
   $10,623   $19,012   $18,693 

b. General and administrative expenses

 

   Year ended December 31, 

(in thousands)

  2024   2023   2022 
Payroll expenses  $831   $912   $1,289 
Compensation to directors   1,216    887    681 
Professional fees   1,029    969    1,294 
Office maintenance and office expenses   105    906    402 
Insurance   351    567    895 
Share Based Compensation   1,149    1,427    1,836 
Other   232    471    707 
   $4,913   $6,139   $7,104 

 

c. Other expenses (income)

 

   Year ended December 31, 
(in thousands)  2024   2023   2022 
Loss on disposal group of assets held for sale  $957   $4,244   $
-
 
Income from cancelation of uncertain tax positions   (605)   
-
    
-
 
   $352   $4,244   $
-
 

 

d. Finance income (expenses), net

 

   Year ended December 31, 
(in thousands)  2024   2023   2022 
Interest income  $1,069   $1,565   $835 
(Loss) income related to marketable securities   
-
    
-
    (1,983)
Exchange differences, net   (182)   (1,224)   (4,101)
Bank commissions and other expenses   (13)   (14)   (14)
   $874   $327   $(5,263)